INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 41h ago
HOUSE PTR1h ago
SEC 13F1h ago
ROBINHOOD CHAIN1h ago
Public company

Ovid Therapeutics Inc.

OVIDCIK 0001636651

EDGAR filingsOpen in network
Price$2.85
1 year+114.3%
Disclosed transactions5
Buys / sells0 / 1
Max Insider Score31
Connections with evidence4

OVID · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
GA
Greka AnnaDirector
OVIDOvid Therapeutics Inc.
Grant or award
A—
130.0K sh
Jun 15, 2026Jun 17, 2026

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 2834 · Pharmaceutical Preparations · Nov 4, 2026
  • ← Insider ofevidence
    Greka AnnaDirector · Jun 17, 2026
  • ← Insider ofevidence
    Fitzgerald Kevin JosephDirector · Apr 9, 2026
  • ← Insider ofevidence
    Alexander Margaret A.Director, President and CEO · Jan 5, 2026
traded Jun 15, 2026
+2d
SEC FORM 4

Evidence

9
FJ
Fitzgerald Kevin JosephDirector
OVIDOvid Therapeutics Inc.
Grant or award
A$45K
17.6K sh
Apr 7, 2026Apr 9, 2026
traded Apr 7, 2026
+2dSEC FORM 4

Evidence

31
AA
Alexander Margaret A.Director, President and CEO
OVIDOvid Therapeutics Inc.
Open-market sale
SELL$17K
11.7K sh
Feb 23, 2026Mar 2, 2026
traded Feb 23, 2026
+7dSEC FORM 4

Evidence

5
AA
Alexander Margaret A.Director, President and CEO
OVIDOvid Therapeutics Inc.
Grant or award
A—
1.44M sh
Feb 26, 2026Mar 2, 2026
traded Feb 26, 2026
+4dSEC FORM 4

Evidence

9
AA
Alexander Margaret A.Director, President and CEO
OVIDOvid Therapeutics Inc.
Grant or award
A—
890.0K sh
Jan 4, 2026Jan 5, 2026
traded Jan 4, 2026
+1dSEC FORM 4

Evidence